October 17, 2017
Salk researchers find that p75 protein is vital for signaling pain in nervous system
Salk researchers find that p75 protein is vital for signaling pain in nervous system
LA JOLLA—Sensory neurons regulate how we recognize pain, touch, and the movement and position of our own bodies, but the field of neuroscience is just beginning to unravel this circuitry. Now, new research from the Salk Institute shows how a protein called p75 is critical for pain signaling, which could one day have implications for treating neurological disorders as well as trauma such as spinal cord injury.
“The p75 protein is a busybody. It plays a role in many different signaling pathways,” says Salk Professor Kuo-Fen Lee, holder of the Helen McLoraine Chair in Molecular Neurobiology and co–senior author of the new work. “This complexity makes the protein interesting to study. In this latest research, we discovered that, in addition to its other functions, it’s also required for the survival of certain pain-sensing neurons.” The results are published October 17, 2017, in Cell Reports.
Previous research by Lee’s lab had shown that p75 is involved in a signaling pathway that regulates the development of sensory neurons—cells which transmit our sensation of pain, touch and muscle tension—in the dorsal root ganglia.
In this latest study, the investigators collaborated with a team at the University of Michigan led by co–senior author Brian Pierchala to further learn about the role of p75 in the development of sensory neurons. They studied mice lacking p75 only in the sensory neurons. When these mice were born, their sensory neurons were normal. But by the time they were six months old, some of those sensory neurons had degenerated, particularly the populations of cells that usually transmit pain signals.
It turned out that p75 partners with another class of receptors, called the GDNF (glial cell–derived neurotrophic factor) receptor family. The p75 protein binds to one such receptor called Ret, which is associated with some neurological conditions as well as certain types of cancer. Members of the GDNF family support the survival of sensory neurons that transmit the pain signal and p75 enhances this survival-promoting effect by interacting with Ret. When p75 was removed, the survival-promoting signal from GDNF family members was reduced and the sensory neurons that need this signal to survive gradually degenerated.
“In this particular study, one of the remarkable findings is that this relationship between Ret and p75 exists at all. It’s something that wasn’t previously known,” says Zhijiang Chen, a postdoctoral fellow in Lee’s lab and one of the paper’s co–first authors. “This research adds further significance to the role of p75 as a master regulator for many different signaling pathways that are vital for the nervous system to function normally.”
Lee says that although he doesn’t know of any human disorders that are associated with the loss of p75 in particular, pain sensation is obviously vital for quality of life. “We do know of people who have these kinds of sensory deficits, and it can be serious problem,” he says. “Thanks to this research, we now know more about the broad influence of the p75 protein.”
Future studies will look at the role p75 plays in two other types of cells—glial cells and skin cells. The investigators also plan to look in more detail at the role of p75 in different parts of the body. “We know that in the sacral region, there is a high percentage of sensory neurons with strong p75 expression,” Lee says.
Other authors on the study are Bertha Dominguez, Yoshinobu Harada, Tasha Bengoechea of Salk; Weichun Lin of UT Southwestern Medical School; and Christopher R. Donnelly and Alan S. Halim of the University of Michigan.
This research was supported by grants from the NIH, the Clayton Foundation, the Schlink Foundation, the Gemcon Family Foundation, and the Joe W. and Dorothy Dorsett Brown Foundation.
JOURNAL
Cell Reports
AUTHORS
Zhijiang Chen, Christopher R. Donnelly, Bertha Dominguez, Yoshinobu Harada, Weichun Lin, Tasha Bengoechea, Alan S. Halim, Brian A. Pierchala and Kuo-Fen Lee
Office of Communications
Tel: (858) 453-4100
press@salk.edu
Unlocking the secrets of life itself is the driving force behind the Salk Institute. Our team of world-class, award-winning scientists pushes the boundaries of knowledge in areas such as neuroscience, cancer research, aging, immunobiology, plant biology, computational biology and more. Founded by Jonas Salk, developer of the first safe and effective polio vaccine, the Institute is an independent, nonprofit research organization and architectural landmark: small by choice, intimate by nature, and fearless in the face of any challenge.